Atrandi Biosciences raised €24M in a Series A round in Feb 2025. The company is based in Vilnius, Lithuania. Investors in the round: GRIDS Capital, Lux Capital, Metaplanet and 2 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
